Drinking 1 cup of caffeinated coffee a day might help lower a person's risk of recurrent AFib episodes by as much as 39%, a ...

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in ...

Different scientific fields have their own ways of evaluating validity. Engineers test new designs against safety and performance standards. Medical researchers use controlled experiments to verify ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical ...

Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary ...

Q3 2025 Earnings Call Transcript November 10, 2025 Myomo, Inc. beats earnings expectations. Reported EPS is $-0.09, ...

Do ultra-processed foods increase type 2 diabetes risk? Explore the link between what we eat and diabetes rates in this evidence-packed research breakdown.

Bo_RC_25 validates and expands the ultra high-grade zone first identified in Bo_RC_14 , reinforcing Borralha's status as one of Europe's most significant tungsten discoveries amid increasing global ...